Vaxart Inc
VXRT0.320USD
-0.107-25.06%
시장 운영 시간 （ET）시세는 15분 지연됩니다
73.03M시가총액
손실P/E TTM
자세한 내용은 Vaxart Inc 회사
Vaxart, Inc. is a clinical-stage biotechnology company that is primarily focused on the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) proprietary oral vaccine platform. Its vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Its development programs include pill vaccines designed to protect against norovirus (cause for acute gastroenteritis), coronavirus, including SARS-CoV-2 (COVID-19)), and influenza. In addition, it has generated preclinical data for its therapeutic vaccine candidate targeting cervical cancer and dysplasia caused by human papillomavirus. The Company's platform technology employs a vector-based approach and consists of various components, such as a vector (adenovirus type 5 (Ad5); an antigen (Ad5 DNA); an adjuvant (Toll-like receptor 3 (TLR3)), and its proprietary enteric-coated tablet.
회사 정보
종목 코드 VXRT
회사 이름Vaxart Inc
상장일Mar 17, 1980
CEOMr. Steven (Steve) Lo
직원 수105
유형Ordinary Share
회계 연도 종료Mar 17
주소170 Harbor Way, Suite 300
도시SOUTH SAN FRANCISCO
증권 거래소US 'Other OTC' and Grey Market
국가United States of America
우편 번호94080
전화16505503500
웹사이트https://vaxart.com/
종목 코드 VXRT
상장일Mar 17, 1980
CEOMr. Steven (Steve) Lo
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+1053.17%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
51.65K
+44.88%
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.14K
-97.54%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Independent Director
Independent Director
--
--
Dr. James F. Cummings, M.D.
Dr. James F. Cummings, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Matt Stein
Matt Stein
IR Contact Officer
IR Contact Officer
--
--
Mr. Kevin P. Finney
Mr. Kevin P. Finney
Independent Director
Independent Director
--
--
Ms. Laurie Hastings
Ms. Laurie Hastings
Senior Vice President of Human Resources
Senior Vice President of Human Resources
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Edward B. Berg
Mr. Edward B. Berg
Senior Vice President, General Counsel
Senior Vice President, General Counsel
435.74K
+1053.17%
Mr. Jeroen Grasman
Mr. Jeroen Grasman
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
Chief Financial Officer, Principal Accounting Officer and Principal Financial Officer
350.00K
--
Dr. Elaine J. Heron, Ph.D.
Dr. Elaine J. Heron, Ph.D.
Independent Director
Independent Director
51.65K
+44.88%
Mr. Steven (Steve) Lo
Mr. Steven (Steve) Lo
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
40.14K
-97.54%
Dr. Sean N. Tucker, Ph.D.
Dr. Sean N. Tucker, Ph.D.
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. W. Mark Watson
Mr. W. Mark Watson
Independent Director
Independent Director
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Fri, May 23
마지막 업데이트: Fri, May 23
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
4.54%
Sio Capital Management, LLC
2.45%
Geode Capital Management, L.L.C.
1.17%
BlackRock Institutional Trust Company, N.A.
0.78%
Millennium Management LLC
0.42%
Other
90.64%
주주
주주
비율
The Vanguard Group, Inc.
4.54%
Sio Capital Management, LLC
2.45%
Geode Capital Management, L.L.C.
1.17%
BlackRock Institutional Trust Company, N.A.
0.78%
Millennium Management LLC
0.42%
Other
90.64%
주주 유형
주주
비율
Investment Advisor
6.33%
Hedge Fund
3.23%
Investment Advisor/Hedge Fund
2.18%
Individual Investor
1.35%
Research Firm
0.26%
Pension Fund
0.05%
Bank and Trust
0.02%
Family Office
0.01%
Other
86.57%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
223
30.63M
13.42%
-33.98M
2025Q1
260
32.73M
14.34%
-33.64M
2024Q4
273
38.15M
16.82%
-29.38M
2024Q3
304
39.77M
17.54%
-31.47M
2024Q2
307
43.16M
19.03%
-9.14M
2024Q1
311
42.29M
24.34%
-1.37M
2023Q4
307
17.70M
11.60%
-12.17M
2023Q3
319
19.94M
13.09%
-20.38M
2023Q2
329
30.49M
20.10%
-12.31M
2023Q1
343
36.99M
27.31%
-14.55M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
10.37M
4.54%
+291.51K
+2.89%
Mar 31, 2025
Sio Capital Management, LLC
5.58M
2.45%
-5.93M
-51.51%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.66M
1.17%
+58.98K
+2.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.78M
0.78%
-9.61K
-0.54%
Mar 31, 2025
Millennium Management LLC
955.87K
0.42%
-2.03M
-68.04%
Mar 31, 2025
Squarepoint Capital LLP
804.48K
0.35%
+287.68K
+55.67%
Mar 31, 2025
State Street Global Advisors (US)
790.25K
0.35%
+101.40K
+14.72%
Mar 31, 2025
Finney Michael J
702.84K
0.31%
+16.00K
+2.33%
Jun 13, 2025
SilverArc Capital Management, LLC
683.83K
0.3%
-393.96K
-36.55%
Mar 31, 2025
Lee (Phillip E.)
631.62K
0.28%
+397.95K
+170.31%
Mar 24, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
Invesco RAFI US 1500 Small-Mid ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Fidelity Nasdaq Composite Index ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
비율0%
Invesco NASDAQ Future Gen 200 ETF
비율0%
Fidelity Nasdaq Composite Index ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
